Skip Navigation

MDMA therapy for PTSD rejected by FDA panel

www.nature.com MDMA therapy for PTSD rejected by FDA panel

Scientific advisers to the US Food and Drug Administration vote overwhelmingly that the risks of MDMA treatment for post-traumatic stress disorder outweigh the benefits.

MDMA therapy for PTSD rejected by FDA panel
5
5 comments